Consultor le portail de référence du conseil en stratégie Consultor le portail de référence du conseil en stratégie

News, elucidation and outlooks
on strategy consulting

Boston Consulting Group’s leading pharmaceuticals specialist, Dr Michael Anstey, has been tempted to cross the pond, having been poached by UK firm Cambridge Innovation Capital. Anstey was a principal in the BCG’s healthcare practice in Toronto, and has extensive experience advising multinational healthcare businesses across North America, Europe, India, and Japan on a broad range of topics, including corporate strategy, sales and marketing, new launches, R&D, medical strategy and M&A. He said: “I must admit, eyebrows were raised and people questioned why I would leave my position at BCG. But we are on the cusp of something fantastic here. It's exciting to be part of an opportunity in a growth phase and I think it's the perfect time to join this world-class team and build something great.”

michael anstey

Source :

Consultor uses Cookies, to offer you the best service possible. If you continue using the website, you agree with our use of cookies.